AIM
NVRO

Aigen Investment Management’s NEVRO CORP. NVRO Stock Holding History

Aigen Investment Management’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-5,092
Closed -$509K – 1358
2020
Q1 		$509K Buy
5,092
+5,090
+254,500% +$612K 0.07% 415
2019
Q4 		$0 Buy
+2
New +$198 ﹤0.01% 1158

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Aigen Investment Management's NVRO Position: Q2 2020 in Review

Aigen Investment Management sold out of NEVRO CORP. (NVRO) in Q2 2020, closing a stake of 5,092 shares — an estimated $509K sold.

Aigen Investment Management first reported a position in NVRO in Q4 2019 and held it in 2 quarters. The position peaked at $509K in Q1 2020. 202 funds tracked by Wall St. Rank hold NVRO as of Q2 2020.

  • Aigen Investment Management reported no remaining NEVRO CORP. position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 5,092 NEVRO CORP. shares in Q2 2020, an estimated $509K.
  • Aigen Investment Management first reported a position in NEVRO CORP. in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's NEVRO CORP. position peaked at $509K in Q1 2020.
  • 202 funds tracked by Wall St. Rank held NEVRO CORP. as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.